
At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
J. David Haddox, DDS, MD, describes how clinicians can determine whether an opioid has abuse-deterrent properties.
J. David Haddox, DDS, MD, describes how clinicians can determine whether an opioid has abuse-deterrent properties.






